Strategies introduced to assess productivity as part of a compensation scheme appeared to improve productivity in research activities and possibly improved clinical productivity, but they had no effect in the area of teaching. Compensation increased at both group and individual levels, particularly among junior faculty. Higher quality evidence about the benefits and harms of such assessment strategies is needed.
This study, empirically investigates how the ownership‐specific variables, location‐specific variables and strategic motives have influenced the ownership structure choices of Finnish manufacturing firms in ten South and south‐east Asian countries from 1980 to 2000. Very few studies in FDIs have been undertaken so far to empirically analyze the ownership‐specific and location‐specific variables together with the strategic motives in order to understand the ownership structure choices of the investing firms. To the best of our knowledge, this is the first study trying to analyze how the ownership‐specific variables, location‐specific variables, and strategic motives have influenced the ownership structure choices of Finnish manufacturing FDIs in Asian countries. The research results indicate that large international experience, low cultural distance, large market size, and high levels of economic welfare in the target country increases the probability of choosing wholly owned subsidiary (WOS) in order to undertake market‐seeking and efficiency‐seeking FDIs. Similarly, it has also been found that low levels of risks in the target country increases the probability to choose WOS in order to undertake risk‐reduction seeking FDIs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.